Advertisement

Scientometrics

, Volume 108, Issue 3, pp 1621–1636 | Cite as

Scientific output of the emerging Cuban biopharmaceutical industry: a scientometric approach

  • Ricardo Arencibia-Jorge
  • Elena Corera-Alvarez
  • Zaida Chinchilla-Rodríguez
  • Félix de Moya-Anegón
Article

Abstract

Cuba has developed a biopharmaceutical sector that involves some of the country’s most relevant scientific institutions. Despite the severe constraints on resources resulting from the U.S. embargo, the results achieved by this sector have contributed to put the country’s health indicators at the same level of high-income nations. Recently, the creation of BioCubaFarma as a cluster of high-technology enterprises organized around a closed cycle model becomes one of the most relevant efforts of the Island in order to make biopharmaceuticals one of the country’s leading export earners. The main aim of the current paper was to characterize BioCubaFarma through a battery of Scopus-based bibliometric indicators. A comparison with the most productive multinational pharmaceutical companies was made. Regression analysis of annual productivity, number of citations, scientific talent pool, innovative knowledge and other citation-based indicators was performed. Differences and similarities between BioCubaFarma and multinational companies in four Scopus subject categories related to this sector were identified. The most productive and visible institutions from BioCubaFarma were also characterized. Qualified human resources, innovative knowledge, leadership, high specialization in the field of vaccines development and non-dependence of international collaboration are strengths of the organization. However, it is still necessary to increase the number of articles published in highly visible journals with the aim to achieve a better citation-based performance. Moreover, to increase the contributions from less-productive institutions, more clinical research published in medical journals and more collaboration with universities and health institutions could also have positive benefits for BioCubaFarma’s pipelines and portfolios.

Keywords

Biopharmaceuticals Pharmaceutical industry Scientometrics Bibliometric indicators Leadership Excellence International collaboration Multinational companies Cuba 

Notes

Acknowledgments

This research was supported by 2015 Postdoctoral Short Visiting Program of the Spanish Instituto de Bienes y Políticas Públicas (IPP) from Consejo Superior de Investigaciones Científicas (CSIC).

References

  1. Ammed, K. K. M., Gupta, R., & Gupta, B. M. (2014). Pharmocology research in India: A scientometric analysis of publications output, 2003–2012. Indian Journal of Pharmaceutical Education and Research, 48(2), 16–34. doi: 10.5530/ijper.48.2.4.CrossRefGoogle Scholar
  2. Araujo-Ruiz, J. A., Van Hooydonk, G., Torricella-Morales, R. G., & Arencibia-Jorge, R. (2005). Cuban scientific articles in ISI Citation Indexes and CubaCiencias databases (1988–2003). Scientometrics, 65(2), 161–171. doi: 10.1007/s11192-005-0265-4.CrossRefGoogle Scholar
  3. Arencibia-Jorge, R., & de Moya-Anegón, F. (2010). Challenges in the study of Cuban scientific output. Scientometrics, 83(3), 723–737. doi: 10.1007/s11192-009-0150-7.CrossRefGoogle Scholar
  4. Arencibia-Jorge, R., Vega-Almeida, R. L., Chinchilla-Rodríguez, Z., Corera-Álvarez, E., & Moya-Anegón, F. (2012). Specialization patterns in the Cuban national health research. Revista Cubana de Salud Publica, 38(SUPPL. 5), 734–747. doi: 10.1590/s0864-34662012000500007.CrossRefGoogle Scholar
  5. Bordons, M., & Zulueta, M. A. (1997). Comparison of research team activity in two biomedical fields. Scientometrics, 40(3), 423–436. doi: 10.1007/bf02459290.CrossRefGoogle Scholar
  6. Bordons, M., Barrigon, S., & Mendez, A. (1996). Spanish investigation in international pharmacy and pharmacology journals from 1980–1989. Medicina Clinica, 106(2), 51–59.Google Scholar
  7. Bordons, M., Zulueta, M. A., & Barrigon, S. (1998). Scientific activity of the most productive Spanish research teams in pharmacology and pharmacy during the period 1986–1993 as covered by the Science Citation Index (SCI). Medicina Clinica, 111(13), 489–495.Google Scholar
  8. Bornmann, L., Moya-Anegon, F., & Leydesdorff, L. (2012). The new excellence indicator in the world report of the SCImago Institutions Rankings 2011. Journal of Informetrics, 6(2), 333–335.CrossRefGoogle Scholar
  9. Braun, T., & Schubert, A. (1997). Dimensions of scientometric indicator datafiles—World science in 1990–1994. Scientometrics, 38, 175–204.CrossRefGoogle Scholar
  10. Calero, C., Van Leeuwen, T. N., & Tijssen, R. J. W. (2007). Research cooperation within the bio-pharmaceutical industry: Network analyses of co-publications within and between firms. Scientometrics, 71(1), 87–99. doi: 10.1007/s11192-007-1650-y.CrossRefGoogle Scholar
  11. Cami, J., Zulueta, M. A., Fernandez, M. T., Bordons, M., & Gomez, I. (1997). Spanish scientific production in biomedicine and health sciences during the period 1990–1993 (Science Citation Index and Social Science Citation Index) and comparison to period 1986–1989. Medicina Clinica, 109(13), 481–496.Google Scholar
  12. Cañedo Andalia, R., Pérez Machín, M., Guzmán Sánchez, M. V., & Rodríguez Labrada, R. (2010). Approaches to visibility of science and scientific production of Cuba in the health area. ACIMED, 21(1), 28–43.Google Scholar
  13. Cañedo Andalia, R., Nodarse Rodríguez, M., Guerrero Pupo, J. C., Amell Muñoz, I., Small Chapman, M. C., & Milord Ramírez, L. J. (2014). Cuban scientific production about health in international databases. Revista Cubana de Informacion en Ciencias de la Salud, 25(4), 442–451.Google Scholar
  14. Cantner, U., & Rake, B. (2014). International research networks in pharmaceuticals: Structure and dynamics. Research Policy, 43(2), 333–348. doi: 10.1016/j.respol.2013.10.016.CrossRefGoogle Scholar
  15. Castillo, A., Caballero, I., & Triana, J. (2013). Economic-financial management modeling for biotechnology enterprises in Cuba. Biotecnologia Aplicada, 30(4), 290–298.Google Scholar
  16. Chinchilla-Rodríguez, Z., Arencibia-Jorge, R., de Moya-Anegón, F., & Corera-Álvarez, E. (2015). Some patterns of Cuban scientific publication in Scopus: The current situation and challenges. Scientometrics,. doi: 10.1007/s11192-015-1568-8.Google Scholar
  17. Cooper, R. S., Kennelly, J. F., & Ordunez-Garcia, P. (2006). Health in Cuba. International Journal of Epidemiology, 35(4), 817–824. doi: 10.1093/ije/dyl175.CrossRefGoogle Scholar
  18. Ding, Z. Q., Ge, J. P., Wu, X. M., & Zheng, X. N. (2013). Bibliometrics evaluation of research performance in pharmacology/pharmacy: China relative to ten representative countries. Scientometrics, 96(3), 829–844. doi: 10.1007/s11192-013-0968-x.CrossRefGoogle Scholar
  19. Frame, J. D. (1977). Mainstream research in Latin America and the Caribbean. Interciencia, 2(3), 143–147.Google Scholar
  20. Glanzel, W. (2000). Science in Scandinavia: a bibliometric approach. Scientometrics, 48, 121–150.CrossRefGoogle Scholar
  21. Gomez, I., Fernandez, M. T., Bordons, M., & Morillo, F. (2004). Spanish scientific output in Medicine in the years 1994–1999. Revista Clinica Espanola, 204(2), 75–88. doi: 10.1157/13058801.Google Scholar
  22. Gorraiz, J., & Schloegl, C. (2008). A bibliometric analysis of pharmacology and pharmacy journals: Scopus versus Web of Science. Journal of Information Science, 34(5), 715–725. doi: 10.1177/0165551507086991.CrossRefGoogle Scholar
  23. Guerrero-Bote, V., Olmeda-Gómez, C., & Moya-Anegon, F. (2013). Quantifying the benefits of international scientific collaboration. Journal of the Association for Information Science and Technology, 64(2), 392–404.CrossRefGoogle Scholar
  24. Huang, M. C., Fang, S. C., & Chang, S. C. (2011). Tracking R&D behavior: Bibliometric analysis of drug patents in the Orange Book. Scientometrics, 88(3), 805–818. doi: 10.1007/s11192-011-0400-3.CrossRefGoogle Scholar
  25. Kissin, I., & Bradley, E. L. (2011). Top Journals Selectivity Index: Is it acceptable for drugs beyond the field of analgesia? Scientometrics, 88(2), 589–597. doi: 10.1007/s11192-011-0403-0.CrossRefGoogle Scholar
  26. Kissin, I., & Bradley, E. L. (2012). Top journals selectivity index and “me-too” drugs. Scientometrics, 91(1), 131–142. doi: 10.1007/s11192-011-0556-x.CrossRefGoogle Scholar
  27. Lage, A. (2006). Socialism and the knowledge economy - Cuban biotechnology. Monthly Review-an Independent Socialist Magazine, 58(7), 50–58.Google Scholar
  28. Lage, A. (2008). Connecting immunology research to public health: Cuban biotechnology. Nature Immunology, 9(2), 109–112. doi: 10.1038/ni0208-109.CrossRefGoogle Scholar
  29. López Mola, E., Silva, R., Acevedo, B., Buxadó, J. A., Aguilera, A., & Herrera, L. (2006). Biotechnology in Cuba: 20 years of scientific, social and economic progress. Journal of Commercial Biotechnology, 13(1), 1–11. doi: 10.1057/palgrave.jcb.3050038.CrossRefGoogle Scholar
  30. Lopez, E., Silva, R., Acevedo, B., Buxado, J. A., Aguilera, A., & Herrera, L. (2007). Taking stock of Cuban biotech. Nature Biotechnology, 25(11), 1215–1216. doi: 10.1038/nbt1107-1215.CrossRefGoogle Scholar
  31. Minguillo, D., Tijssen, R., & Thelwall, M. (2015). Do science parks promote research and technology? A scientometric analysis of the UK. Scientometrics, 102(1), 701–725. doi: 10.1007/s11192-014-1435-z.CrossRefGoogle Scholar
  32. Mohammadhassanzadeh, H., Samadikuchaksaraei, A., Shokraneh, F., Valinejad, A., Abolghasem-Gorji, H., & Yue, C. (2010). A bibliometric overview of 30 years of medical sciences productivity in Iran. Archives of Iranian Medicine, 13(4), 313–317.Google Scholar
  33. Moya-Anegon, F., Guerrero-Bote, V., Bornmann, L., & Moed, H. F. (2013). The research guarantors of scientific papers and the output counting: A promising new approach. Scientometrics, 97, 421–434.CrossRefGoogle Scholar
  34. Natsukawa, T., Gemba, K., & Ishida, S. (2013). The timing of interorganisational collaborations in an emerging biopharmaceutical field: Evidence from Japan in comparison to the remaining RNAi field. Technology Analysis & Strategic Management, 25(5), 583–597. doi: 10.1080/09537325.2013.785509.CrossRefGoogle Scholar
  35. Olmeda-Gomez, C., Perianes-Rodriguez, A., Ovalle-Perandones, M. A., & Moya-Anegon, F. (2008). Comparative analysis of university-government-enterprise co-authorship networks in three scientific domains in the region of Madrid. Information Research-an International Electronic Journal, 13(3), 352.Google Scholar
  36. Pérez Ones, I., & Jover, J. N. (2009). Higher education and socio-economic development in Cuba: High rewards of a risky high-tech strategy. Science and Public Policy, 36(2), 97–101. doi: 10.3152/030234209x413900.CrossRefGoogle Scholar
  37. Perianes-Rodriguez, A., Olmeda-Gomez, C., Ovalle-Perandones, M. A., Chinchilla-Rodriguez, Z., & Moya-Anegon, F. (2011). R&D collaboration in 50 major Spanish companies. Aslib Proceedings, 63(1), 5–27. doi: 10.1108/00012531111103759.CrossRefGoogle Scholar
  38. Rehn, C., Kronman, U., & Wadskog, D. (2007). Bibliometric indicators: Definitions and usage at Karolinska Institutet version 10. Stockholm: Karolinska Institutet University Library.Google Scholar
  39. Sáenz, T. W. (2005). Biotechnology for medical applications: The Cuban experience. Science Technology & Society, 10(2), 225–248. doi: 10.1177/097172180501000203.CrossRefGoogle Scholar
  40. Sancho, R., Bernal, G., & Gálvez, L. (1993). Approach to the Cuban scientific activity by using publication based quantitative indicators (1985-1989). Scientometrics, 28(3), 297–312. doi: 10.1007/bf02026512.CrossRefGoogle Scholar
  41. Thompson, D. F., & Nahata, M. C. (2012). Pharmaceutical science faculty publication records at research-intensive pharmacy colleges and schools. American Journal of Pharmaceutical Education, 76(9), 173.CrossRefGoogle Scholar
  42. Tijssen, R. J. W. (2009). Internationalisation of pharmaceutical R&D: How globalised are Europe’s largest multinational companies? Technology Analysis & Strategic Management, 21(7), 859–879. doi: 10.1080/09537320903182330.CrossRefGoogle Scholar
  43. Zacca-González, G., Vargas-Quesada, B., Chinchilla-Rodríguez, Z., & De Moya-Anegón, F. (2014). Cuban scientific production in medicine and public health: Scopus 2003–2011. Transinformacao, 26(3), 281–293. doi: 10.1590/0103-37862014000300005.CrossRefGoogle Scholar
  44. Zacca-González, G., Chinchilla-Rodríguez, Z., Vargas-Quesada, B., & de Moya-Anegón, F. (2015). Patterns of communication and impact of the Cuban scientific output in public health. Revista Cubana de Salud Publica, 41(2), 200–216.Google Scholar
  45. Zhao, Q. J., & Guan, J. C. (2011). International collaboration of three ‘giants’ with the G7 countries in emerging nanobiopharmaceuticals. Scientometrics, 87(1), 159–170. doi: 10.1007/s11192-010-0311-8.CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2016

Authors and Affiliations

  1. 1.National Center for Scientific Research (CNIC)HavanaCuba
  2. 2.SciMago Research Group, Institute of Policies and Public GoodsCCHS-CSICMadridSpain

Personalised recommendations